U.S. Pharma Stock News

Recent commentary on Origin Bancorp highlights that, despite a strong six-month performance versus the broader market, analysts are increasingly focused on the bank’s modest long-term revenue growth, below-standard net interest margin, and limited expected tangible book value per share expansion. This contrast between recent share outperformance and concerns about underlying profitability and balance sheet growth raises questions about how durable Origin Bancorp’s current profile really...

If you are wondering whether Bloom Energy's share price actually lines up with its underlying value, or if the story has run ahead of the numbers, this article will walk through what the data currently suggests. The stock last closed at US$157.17, with returns of 5.7% over 30 days, a 59.3% gain year to date, and very large gains over 1 year and 3 years, which can change how investors think about both upside potential and risk. Recent headlines have focused on Bloom Energy's role in clean...

In March 2026, Compass Therapeutics, Inc. filed a shelf registration to offer up to 11,132,940 shares of common stock, valued at about US$62.23 million, in connection with its employee stock ownership plans. This move follows the company’s recently reported 2025 net loss of US$66.49 million, highlighting an ongoing need to support operations through potential equity financing. We will now examine how Compass Therapeutics’ sizeable shelf registration for an employee-related equity offering...

BETA Technologies (BETA) is back in focus after Surf Air Mobility agreed to buy 25 ALIA CTOL aircraft, with options for up to 75 more, to launch commercial electric passenger services starting in Hawaii. See our latest analysis for BETA Technologies. The Surf Air Mobility deal follows a busy few weeks that included full year 2025 results, updated 2026 revenue guidance and selection for seven of eight federal eVTOL Integration Pilot Programs. Despite these developments, the share price remains...

Instacart parent Maplebear (NasdaqGS:CART) has partnered with Fareway to roll out an upgraded digital grocery experience using Storefront Pro and the Instacart Marketplace. The collaboration introduces no markup pickup orders and targets higher e commerce usage across Fareway’s 140+ stores in the Midwest. The partnership expands Maplebear’s enterprise commerce platform and extends its reach with a sizable regional grocer. For investors watching NasdaqGS:CART at a share price of $37.71, this...

Unum Group (UNM) is back on investors’ radar after recent share price swings, with short term returns mixed across the past week, month, and past 3 months. This has prompted closer attention to its fundamentals. See our latest analysis for Unum Group. At a share price of US$72.69, Unum Group’s recent moves include a 1-day share price return of 0.25% and a 30-day share price return of 1.32%. The year to date share price return of 5.88% and 1-year total shareholder return of 3.57% sit against a...

Event overview and why Universal (UVV) is in focus Universal (UVV) is back on investors’ radar after management acknowledged that tobacco oversupply is affecting its core tobacco operations, while its ingredients diversification business recorded an operating loss in Q3 FY2026. To address these pressures, the company expanded its credit facility by US$250 million and appointed a new CFO. These steps reshape its financial flexibility and leadership profile at a time when both business segments...

CSG Systems International (NasdaqGS:CSGS) has agreed to be acquired by NEC Corporation. The deal marks a change in ownership that is expected to reshape how the company is positioned within the broader technology and communications sector. The acquisition terms center on CSG Systems International's current share price of $79.79 and its existing shareholder base. For current shareholders, this news follows a period in which NasdaqGS:CSGS has recorded a 36.7% return over 1 year, 64.1% over 3...

Lantheus Holdings recently received FDA approval for PYLARIFY TruVu, an enhanced formulation of its PSMA PET imaging agent for prostate cancer, and tentative FDA approval for a radioequivalent version of LUTATHERA for somatostatin receptor–positive neuroendocrine tumors. These approvals build directly on the clinical evidence and commercial footprint of PYLARIFY, potentially strengthening Lantheus’s position across prostate and neuroendocrine tumor imaging while improving manufacturing...

Wyndham Hotels & Resorts (WH) just raised its quarterly cash dividend to US$0.43 per share, a 5% increase from 2025. This development puts the stock’s income profile firmly in focus for investors. See our latest analysis for Wyndham Hotels & Resorts. The higher dividend comes after a softer run in the stock, with a 7 day share price return of 7.5% and a 30 day share price return of 8.3%, while the 1 year total shareholder return is 14.4%. Longer term 3 and 5 year total shareholder returns of...

Perrigo Company plc recently took part in the UBS Global Consumer and Retail Conference in New York, where President and CEO Patrick Lockwood-Taylor presented the company’s outlook and priorities to investors and industry participants. This conference appearance gave investors a direct window into management’s latest thinking on business focus, operational initiatives, and potential portfolio evolution, which can influence how the company’s longer-term position is understood. Next, we’ll...

ServiceTitan, Inc. recently reported fourth-quarter and full-year 2026 results showing higher revenue and a smaller net loss year-on-year, while issuing new revenue guidance for the coming quarter and fiscal year. The company also appointed Abhishek “Abhi” Mathur as Chief Technology and Product Officer, highlighting an intensified push to embed AI across its contractor-focused platform. Next, we’ll examine how Mathur’s AI-focused remit at ServiceTitan could influence the company’s existing...

In March 2026, Yalla Group Limited reported its fourth-quarter and full-year 2025 results, showing broadly stable revenue alongside higher net income and earnings per share, and issued first-quarter 2026 revenue guidance that factors in the timing of Ramadan. On the same day, Yalla unveiled a new 24‑month share repurchase program of up to US$150,000,000, following the completion of a prior buyback that retired just over 10% of its shares, signaling a continued focus on returning excess cash...

Why Ovintiv’s latest filing matters for shareholders Ovintiv (OVV) recently filed an omnibus shelf registration covering debt, common and preferred stock, warrants, units, and share purchase securities. This filing gives the company flexibility to raise capital through multiple instruments over time. See our latest analysis for Ovintiv. At a share price of $54.93, Ovintiv has seen a 30 day share price return of 17.80% and a year to date share price return of 35.66%, while the 5 year total...

Imperial Petroleum Inc. recently reported fourth-quarter 2025 results, with sales of US$51.14 million and net income of US$14.96 million, and also declared a US$0.546875 preferred dividend on its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock for payment on March 30, 2026. While quarterly sales and earnings increased compared with the prior year’s quarter, full-year 2025 net income and earnings per share from continuing operations remained broadly in line with 2024 levels,...

If you are wondering whether United Community Banks is starting to look like good value, you are not alone, especially with the share price back on many investors' radar. The stock closed at US$30.18, with a 7 day return of 5.8% decline, a 30 day return of 14.7% decline, and a 1 year return of 12.7%, a mix that can change how investors see both its potential and its risks. Recent news coverage around United Community Banks has focused on its position within the regional banking sector and...

Preformed Line Products (PLPC) recently reported fourth quarter and full year 2025 results, showing higher net sales and a larger order backlog, alongside lower net income as tariffs and inventory adjustments weighed on profitability. See our latest analysis for Preformed Line Products. Preformed Line Products’ share price has climbed 23.08% year to date and its 1 year total shareholder return of 112.20% far outpaces the 90 day share price return of 12.54%. This suggests that momentum may...

Wondering if Kohl's share price still reflects its true worth, or if the recent volatility has created a potential mispricing worth a closer look. The stock closed at US$13.27, with recent returns showing a 15.3% decline over 7 days and a 23.3% decline over 30 days, while the 1 year return sits at 68.4%. These swings sit against a longer backdrop where the 3 year return is a 29.8% decline and the 5 year return is a 70.3% decline. Short term moves can look very different from the longer track...

On 3 March 2026, HCI Group, Inc. announced that its Board of Directors had authorized a one-year share repurchase program of up to US$80,000,000 of its common stock. This buyback authorization can be read as management choosing to allocate capital back to shareholders, potentially altering the company’s future capital structure and per-share metrics. We’ll now examine how HCI Group’s new US$80,000,000 repurchase authorization could influence its investment narrative and future capital...

Trupanion (NasdaqGM:TRUP) announced a new partnership with the Human Animal Bond Research Institute (HABRI). The collaboration focuses on research and advocacy that supports the human and animal connection, including pet owners, veterans, service animals, and special populations. The initiative aims to use data driven insights to inform programs and policies that affect pet and human welfare. For you as an investor, this adds another layer to Trupanion's core pet insurance business. The...

UiPath (PATH) just posted its FY 2026 Q4 scorecard with revenue of US$481.1 million and basic EPS of US$0.19, alongside net income of US$104.5 million, putting a clear spotlight on how its automation platform is now feeding through to the bottom line. The company has seen quarterly revenue move from US$354.7 million in FY 2025 Q3 to US$423.6 million in FY 2025 Q4, then to US$356.6 million, US$361.7 million, US$411.1 million and now US$481.1 million in FY 2026 Q4. Basic EPS over those same...

This article walks through the key numbers so you can judge for yourself whether Clarivate's current share price reflects its true worth or if the market is still mispricing the story. Over the past month, Clarivate's share price is up 25.7%, although the stock still shows a 20.1% decline year to date and a 35.1% decline over the last year, with longer term returns over 3 and 5 years also in negative territory. Recent coverage around Clarivate has focused on its role as a data and analytics...

For investors wondering whether Kadant, at around US$321 per share, is priced for perfection or offering value, this article walks through what the numbers say about the stock. The share price is up 12.2% year to date. However, the past 7 days and 30 days show returns of 7.1% and 5.1% declines, and the 1 year return is a 4.5% decline, following a stronger 61.9% 3 year and 85.0% 5 year performance. Recent news coverage has focused on Kadant's role in capital goods markets and how investors...

Abacus Global Management, Inc. reported past fourth-quarter 2025 revenue of US$71.9 million, up from US$33.21 million a year earlier, and turned a prior net loss of US$18.26 million into net income of US$7.23 million, with basic earnings per share from continuing operations improving from a loss of US$0.22 to earnings of US$0.07. For 2025 as a whole, the company’s revenue more than doubled to US$235.24 million and it moved from a full-year net loss of US$23.96 million to net income of...